SABSW - SAB Biotherapeutics Inc - Warrants (25/07/2027)
Previous close
0.0469
0 0%
Share volume: 399
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.05
0.00
0.00%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
58.33%
1 Month
-5.00%
3 Months
90.00%
6 Months
58.33%
1 Year
-37.58%
2 Year
-48.59%
Key data
Stock price
$0.05
DAY RANGE
$0.03 - N/A
52 WEEK RANGE
$0.01 - $0.19
52 WEEK CHANGE
-$0.41
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website: sabbiotherapeutics.com
Employees: 81
IPO year: -
Issue type:
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: sabbiotherapeutics.com
Employees: 81
IPO year: -
Issue type:
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
sab biotherapeutics is a clinical-stage biopharmaceutical development company using its novel immunotherapy platform to produce life-saving therapies.
Recent news